IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Journal of Cancer Research and Therapeutics

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on October 31, 2023

Impact Score

2022-2023

1.24

h-Index

2022-2023

 47

Rank

2022-2023

 13621

SJR

2022-2023

 0.353

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Journal of Cancer Research and Therapeutics
Abbreviation J. Cancer Res. Ther.
Publication Type Journal
Subject Area, Categories, Scope Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)
h-index 47
Overall Rank/Ranking 13621
SCImago Journal Rank (SJR) 0.353
Impact Score 1.24
Publisher Wolters Kluwer Medknow Publications
Country India
ISSN 09731482, 09741127
Best Quartile Q3
Coverage History 2005-2022




Aim and Scope


The Journal of Cancer Research and Therapeutics (JCRT), the official publication of Association of Radiation Oncologists of India (AROI). The JCRT, a quarterly publication, dedicated to basic and clinical sciences in oncology including radiation oncology.


About Journal of Cancer Research and Therapeutics


Journal of Cancer Research and Therapeutics is a journal covering the technologies/fields/categories related to Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3). It is published by Wolters Kluwer Medknow Publications. The overall rank of Journal of Cancer Research and Therapeutics is 13621. According to SCImago Journal Rank (SJR), this journal is ranked 0.353. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 47. The best quartile for this journal is Q3.

The ISSN of Journal of Cancer Research and Therapeutics journal is 09731482, 09741127. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Journal of Cancer Research and Therapeutics is cited by a total of 1324 articles during the last 3 years (Preceding 2022).


Journal of Cancer Research and Therapeutics Impact IF 2022-2023


The Impact IF 2022 of Journal of Cancer Research and Therapeutics is 1.24, which is computed in 2023 as per its definition. Journal of Cancer Research and Therapeutics IF is decreased by a factor of 0.05 and approximate percentage change is -3.88% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Journal of Cancer Research and Therapeutics Impact IF 2023 Prediction


Impact IF 2022 of Journal of Cancer Research and Therapeutics is 1.24. If the same downward trend persists, Impact IF may fall in 2023 as well.


Impact IF Trend


Year wise Impact IF of Journal of Cancer Research and Therapeutics. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2022 1.24
2021 1.29
2020 1.51
2019 1.30
2018 1.37
2017 0.87
2016 0.85
2015 0.88
2014 0.96

Journal of Cancer Research and Therapeutics h-index


  Table Setting

Journal of Cancer Research and Therapeutics has an h-index of 47. It means 47 articles of this journal have more than 47 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Journal of Cancer Research and Therapeutics ISSN


The ISSN of Journal of Cancer Research and Therapeutics is 09731482, 09741127. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Journal of Cancer Research and Therapeutics Rank and SCImago Journal Rank (SJR)


The overall rank of Journal of Cancer Research and Therapeutics is 13621. According to SCImago Journal Rank (SJR), this journal is ranked 0.353. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Journal of Cancer Research and Therapeutics by Year


Year SJR
2023/2024 Coming Soon
2022 0.353
2021 0.363
2020 0.475
2019 0.461
2018 0.420
2017 0.400
2016 0.324
2015 0.372
2014 0.329

Ranking of Journal of Cancer Research and Therapeutics by Year


Year Ranking
2023/2024 Coming Soon
2022 13621
2021 12982
2020 10521
2019 10539
2018 10932
2017 10956
2016 12817
2015 11513
2014 12196

Journal of Cancer Research and Therapeutics Publisher


Table Setting

Journal of Cancer Research and Therapeutics is published by Wolters Kluwer Medknow Publications. It's publishing house is located in India. Coverage history of this journal is as following: 2005-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Journal of Cancer Research and Therapeutics is J. Cancer Res. Ther.. This abbreviation ('J. Cancer Res. Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Journal of Cancer Research and Therapeutics


If your research field is/are related to Medicine (miscellaneous) (Q3); Oncology (Q3); Radiology, Nuclear Medicine and Imaging (Q3), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Journal of Cancer Research and Therapeutics?

Journal of Cancer Research and Therapeutics latest impact IF is 1.24. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 1.51 (2020) and 0.85 (2016), respectively, in the last 9 years. Moreover, its average IS is 1.14 in the previous 9 years.


What's the SCImago Journal Rank (SJR) of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics has an SJR (SCImago Journal Rank) of 0.353, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.475 in 2020 and the lowest being 0.324 in 2016. Furthermore, the average SJR of the Journal of Cancer Research and Therapeutics over the previous 9-year period stands at 1.14.


What's the latest h-index of the Journal of Cancer Research and Therapeutics?

The latest h-index of the Journal of Cancer Research and Therapeutics is 47.


Who's the publisher of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics is published by the Wolters Kluwer Medknow Publications, with its country of publication being the India.


What's the current ranking of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics is currently ranked 13621 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 10521 in 2020 and its lowest position of 13621 in 2022.


What's the abbreviation or short name for the Journal of Cancer Research and Therapeutics?

The standard ISO4 abbreviation for the Journal of Cancer Research and Therapeutics is J. Cancer Res. Ther..


Is the "Journal of Cancer Research and Therapeutics" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Journal of Cancer Research and Therapeutics is classified as a journal that the Wolters Kluwer Medknow Publications publishes.


What's the scope or major areas of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics encompasses the following areas:

  • Medicine (miscellaneous)
  • Oncology
  • Radiology, Nuclear Medicine and Imaging

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 09731482, 09741127.


What's the best quartile of the Journal of Cancer Research and Therapeutics?

The best quartile for the Journal of Cancer Research and Therapeutics is Q3 (2022).


What's the coverage history of the Journal of Cancer Research and Therapeutics?

The Journal of Cancer Research and Therapeutics coverage history can be summarized as follows: 2005-2022.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Dermatologia Kliniczna journal 25442 Cornetis 7 0.00
Clinical Medicine and Research journal 16602 Marshfield Clinic 60 1.06
Istanbul University - Journal of Electrical and Electronics Engineering journal 24654 University of Istanbul 0 0.00
Journal of Supply Chain Management journal 378 Wiley-Blackwell 104 12.58
Air and Space Power Journal (discontinued) journal 28397 AU Press 9 0.20
Population Review journal 17841 Sociological Demography Press 13 0.73
Museum Management and Curatorship journal 8168 Routledge 37 2.65
Journal of Sociology journal 6009 SAGE Publications Ltd 58 3.21
Engenharia Agricola journal 15839 Sociedade Brasileira de Engenharia Agricola 30 1.12
European Journal of Wildlife Research journal 8709 Springer Verlag 56 1.99

Check complete list




Year wise Impact Score (IS) of Journal of Cancer Research and Therapeutics

Impact Score Table

Year Impact Score (IS)
2023/2024 Coming Soon
2022 1.24
2021 1.29
2020 1.51
2019 1.30
2018 1.37
2017 0.87
2016 0.85
2015 0.88
2014 0.96



Top Journals/Conferences in Medicine (miscellaneous)

New England Journal of Medicine
Massachussetts Medical Society | United States

Nature Medicine
Nature Publishing Group | United Kingdom

MMWR Recommendations and Reports
Centers for Disease Control and Prevention (CDC) | United States

Nature Reviews Drug Discovery
Nature Publishing Group | United Kingdom

Nature Reviews Immunology
Nature Publishing Group | United Kingdom

Morbidity and Mortality Weekly Report
Department of Health and Human Services | United States

Lancet, The
Elsevier Ltd. | United Kingdom

Physiological Reviews
American Physiological Society | United States

MMWR supplements
Epidemiology Program Office | United States

Annals of Oncology
Elsevier Ltd. | United Kingdom

See All

Top Journals/Conferences in Oncology

Ca-A Cancer Journal for Clinicians
Wiley-Blackwell | United States

Nature Reviews Cancer
Nature Publishing Group | United Kingdom

Nature Reviews Clinical Oncology
Nature Publishing Group | United Kingdom

Cancer Cell
Cell Press | United States

Lancet Oncology, The
Elsevier Ltd. | United Kingdom

Annals of Oncology
Elsevier Ltd. | United Kingdom

Journal of Clinical Oncology
Lippincott Williams and Wilkins Ltd. | United States

Nature Cancer
| United States

Molecular Cancer
BioMed Central Ltd. | United Kingdom

JAMA Oncology
American Medical Association | United States

See All

Top Journals/Conferences in Radiology, Nuclear Medicine and Imaging

JACC: Cardiovascular Imaging
Elsevier Inc. | United States

Radiology
Radiological Society of North America Inc. | United States

Cancer Treatment Reviews
W.B. Saunders Ltd | United Kingdom

Medical Image Analysis
Elsevier | Netherlands

European urology oncology
Elsevier BV | Netherlands

Ultrasound in Obstetrics and Gynecology
John Wiley and Sons Ltd | United Kingdom

Radiology: Artificial Intelligence
Radiological Society of North America Inc. | United States

Investigative Radiology
Lippincott Williams and Wilkins Ltd. | United States

European Heart Journal Cardiovascular Imaging
Oxford University Press | United Kingdom

Journal of Cardiovascular Magnetic Resonance
BioMed Central Ltd. | United Kingdom

See All